» Articles » PMID: 35281921

New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases

Overview
Journal Front Pharmacol
Date 2022 Mar 14
PMID 35281921
Authors
Affiliations
Soon will be listed here.
Abstract

CCR7, collaborated with its ligands CCL19 and CCL21, controls extensive migratory events in the immune system. CCR7-bearing dendritic cells can swarm into T-cell zones in lymph nodes, initiating the antigen presentation and T-cell response. Abnormal expression of CCR7 in dendritic cells will cause a series of inflammatory diseases due to the chaotic dendritic cell trafficking. In this review, we take an in-depth look at the structural-functional domains of CCR7 and CCR7-bearing dendritic cell trajectory to lymph nodes. Then, we summarize the regulatory network of CCR7, including transcriptional regulation, translational and posttranslational regulation, internalization, desensitization, and recycling. Furthermore, the potential strategies of targeting the CCR7 network to regulate dendritic cell migration and to deal with inflammatory diseases are integrated, which not only emphasizes the possibility of CCR7 to be a potential target of immunotherapy but also has an implication on the homing of dendritic cells to benefit inflammatory diseases.

Citing Articles

Biomarker expression level changes within rectal gut-associated lymphoid tissues in spinal cord-injured rats.

Zhou Y, Hubscher C Immunohorizons. 2025; 9(4).

PMID: 40048710 PMC: 11884801. DOI: 10.1093/immhor/vlaf002.


Leukemia-Derived Dendritic Cells Induce Anti-Leukemic Effects Ex Vivo in AML Independently of Patients' Clinical and Biological Features.

Klauer L, Rejeski H, Ugur S, Rackl E, Abdulmajid J, Fischer Z Int J Mol Sci. 2025; 26(4).

PMID: 40004163 PMC: 11855365. DOI: 10.3390/ijms26041700.


Causal effects of circulating immune cells on coronary atherosclerosis: Evidence from Mendelian randomization.

Yang X, Yu Y, Hu G, Bai S, Wu J, Guo C Medicine (Baltimore). 2025; 104(5):e41361.

PMID: 39889170 PMC: 11789883. DOI: 10.1097/MD.0000000000041361.


PD-L1-CD80 interactions are required for intracellular signaling necessary for dendritic cell migration.

Kantheti U, Forward T, Lucas E, Schafer J, Tamburini P, Burchill M Sci Adv. 2025; 11(5):eadt3044.

PMID: 39879305 PMC: 11777207. DOI: 10.1126/sciadv.adt3044.


Single-cell transcriptomics of bronchoalveolar lavage during PRRSV infection with different virulence.

Lim B, Kim S, Kim H, Kim J, Seo Y, Lim C Nat Commun. 2025; 16(1):1112.

PMID: 39875369 PMC: 11775223. DOI: 10.1038/s41467-024-54676-2.


References
1.
Han J, Liu Y, Yang S, Wu X, Li H, Wang Q . MEK inhibitors for the treatment of non-small cell lung cancer. J Hematol Oncol. 2021; 14(1):1. PMC: 7786519. DOI: 10.1186/s13045-020-01025-7. View

2.
Vander Lugt B, Khan A, Hackney J, Agrawal S, Lesch J, Zhou M . Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol. 2013; 15(2):161-7. DOI: 10.1038/ni.2795. View

3.
Yang X, Lian K, Meng T, Liu X, Miao J, Tan Y . Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity. ACS Appl Mater Interfaces. 2018; 10(39):33532-33544. DOI: 10.1021/acsami.8b10081. View

4.
Steen A, Larsen O, Thiele S, Rosenkilde M . Biased and g protein-independent signaling of chemokine receptors. Front Immunol. 2014; 5:277. PMC: 4066200. DOI: 10.3389/fimmu.2014.00277. View

5.
Tang G, Du R, Tang Z, Kuang Y . MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway. J Cell Biochem. 2017; 119(4):3725-3731. DOI: 10.1002/jcb.26595. View